Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer

Colaboración

Año: 2024

Molina-Alejandre, M; Perea, F; Calvo, V; Martinez-Toledo, C; Nadal, E; Sierra-Rodero, B; Casarrubios, M; Casal-Rubio, J; Martinez-Martí, A; Insa, A; Massuti, B; Viteri, S; Aranda, IB; Rodriguez-Abreu, D; de Castro, J; Martínez, JM; Cobo, M; Wistuba, II; Parra, ER; Martín-López, J; Megías, D; Muñoz-Viana, R; Garrido, F; Aptsiauri, N; Ruiz-Cabello, F; Provencio, M; Cruz-Bermúdez, A

Título: JOURNAL FOR IMMUNOTHERAPY OF CANCER

• D1